It’s soaring on hopes for a coronavirus treatment.
Since losing a takeover battle with a competitor, it’s caught a second wind of growth leaving its one-time rival in the dust.
It may be your last good chance to get in.
It’s set for a turnaround.
It’s being bought by bargain hunters but remains a good long-term play.
You may have to wait for the market to wake up, but your patience should be rewarded.
The clouds are lifting and traders and investors alike are certain to benefit.
In today’s market, it’s an aggressive play… but it’s a good one.
It’s proven through its recent travails that it remains a great long-term holding. It may be the best marketing company in America.
Over the last three months it’s down 17%. But if you want to build a portfolio focused on growth, its fall has only made it a better value.